Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

This study has been completed.
Sponsor:
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00178152
First received: September 12, 2005
Last updated: May 11, 2011
Last verified: May 2011

September 12, 2005
May 11, 2011
May 2005
November 2005   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00178152 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
The Implication of Erythema Toxicum Neonatorum in Newborns on the Development of Future Asthma

Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

Case studies will include subjects between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years. Patients will be selected based upon their ICD9 codes for asthma. Control subjects will be age matched and without an asthma diagnosis.

  • Asthma
  • Erythema Toxicum Neonatorum
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
334
November 2005
November 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years.
  • Control subjects will be age matched and without an asthma diagnosis.

Exclusion Criteria:

  • Children without accessible medical records
Both
3 Years to 9 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00178152
11627
Not Provided
Jill S. Halterman, MD, MPH, University of Rochester
University of Rochester
Not Provided
Principal Investigator: Jill S Halterman, MD, MPH University of Rochester
Study Chair: Ritu Pabby, MD West Penn Allegheny Health System
University of Rochester
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP